PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

  • Домашняя страница
    • О сайте
  • Материалы
    • Быстрые команды R Project
    • Ссылки
  • Инструменты
    • Рандомизационный список
  • Блог
    • Статистика
    • Phoenix WinNonlin
    • IT
    • Путевые заметки
  • Контакты
    • Контактные данные
    • Консультации
    • Конфиденциальность
  • Профиль
    • Войти
    • Зарегистрироваться

Julia:ReplicateBE – release 0.2.0

Опубликовано 26 октября, 201926 октября, 2019 frozencat

doiGitHub

Вот и подоспел релиз 0.2.0 для оценки параметров смешанной модели репликативного дизайна биоэквивалентности по методу С (EMA) – FDA model.

 

Рубрики: IT, Julia, Mixed Model, Биоэквивалентность

Навигация по записям

Предыдущая запись: ClinicalTrialUtilities: обзор
Следующая запись: Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4

Свежие записи

  • Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
  • Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
  • Главные ошибки при формировании базы данных в MS Excel
  • Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
  • Julia:ReplicateBE – release 0.2.0

Галерея

20170730 161346
20180129 132857
20180815 152156
IMG-20170807-WA0033
DJI 0076
20170731 011047
  • Human medicines European public assessment report (EPAR): Otezla, apremilast, Date of authorisation: 15/01/2015, Revision: 24, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-16
  • Novel Drug Approvals for 2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-15 By FDA
  • Drug Trials Snapshots
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-15 By FDA
  • Drug Trials Snapshot: VANRAFIA
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-15 By FDA
  • Patient Engagement Collaborative
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-15 By FDA
  • Biosimilar Product Information
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-15 By FDA
  • FDA and Kratom
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-15 By FDA
  • European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure
    Source: EMA - Regulatory and procedural guidelines (human and veterinary) Published on 2025-07-15
  • European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes
    Source: EMA - Regulatory and procedural guidelines (human and veterinary) Published on 2025-07-15
  • European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with track changes
    Source: EMA - Regulatory and procedural guidelines (human and veterinary) Published on 2025-07-15
  • Human medicines European public assessment report (EPAR): Yesintek, ustekinumab, Date of authorisation: 14/02/2025, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-15
  • Blood Guidances
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-07-15 By FDA
  • Patent Certifications and Suitability Petitions
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-15 By FDA
  • Recommendations for Testing Blood Donations for Hepatitis B Surface Antigen
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-07-15 By FDA
  • Human medicines European public assessment report (EPAR): Trabectedin Accord, trabectedin, Date of authorisation: 25/04/2025, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-15
Предыдущие записи
Тема: Scaffold от Danny Cooper.